University of Surrey

Test tubes in the lab Research in the ATI Dance Research

Items where Author is "Coffin, R"

Up a level
Export as [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Number of items: 14.

Article

Simpson, GR, Horvath, A, Annels, NE, Pencavel, T, Metcalf, S, Seth, R, Peschard, P, Price, T, Coffin, RS, Mostafid, H, Melcher, AA, Harrington, KJ and Pandha, HS (2012) Combination of a fusogenic glycoprotein, pro-drug activation and oncolytic HSV as an intravesical therapy for superficial bladder cancer BRITISH JOURNAL OF CANCER, 106 (3). pp. 496-507.

Wong, J, Kelly, K, Mittra, A, Gonzalez, SJ, Song, KY, Simpson, G, Coffin, R and Fong, Y (2010) A Third-Generation Herpesvirus Is Effective Against Gastroesophageal Cancer JOURNAL OF SURGICAL RESEARCH, 163 (2). pp. 214-220.

Anesti, A-M, Simpson, GR, Price, T, Pandha, HS and Coffin, RS (2010) Expression of RNA interference triggers from an oncolytic herpes simplex virus results in specific silencing in tumour cells in vitro and tumours in vivo BMC CANCER, 10, ARTN 4.

Price, DL, Lin, S-F, Han, Z, Simpson, G, Coffin, RS, Wong, J, Li, S, Fong, Y and Wong, RJ (2010) Oncolysis Using Herpes Simplex Virus Type 1 Engineered to Express Cytosine Deaminase and a Fusogenic Glycoprotein for Head and Neck Squamous Cell Carcinoma ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 136 (2). pp. 151-158.

Horvath, A, Simpson, GR, Coffin, RS, Mostafid, H and Pandha, H (2009) NOVEL INTRAVESICAL THERAPY FOR NON MUSCLE INVASIVE BLADDER CANCER: COMBINATION OF A FUSOGENIC GLYCOPROTEIN, PRO-DRUG ACTIVATION AND ONCOLYTIC HERPES SIMPLEX VIRUS EUR UROL SUPPL, 8 (4). p. 196.

Simpson, GR and Coffin, RS (2009) Construction and characterization of an oncolytic HSV vector containing a fusogenic glycoprotein and prodrug activation for enhanced local tumor control. Methods Mol Biol, 542. pp. 551-564.

Han, ZQ, Assenberg, M, Liu, BL, Wang, YB, Simpson, G, Thomas, S and Coffin, RS (2007) Development of a second-generation oncolytic Herpes simplex virus expressing TNF alpha for cancer therapy JOURNAL OF GENE MEDICINE, 9 (2). pp. 99-106.

Hu, JC, Coffin, RS, Graham, NJ, Groves, N, Guest, PJ, Harrington, KJ, James, ND, Love, CA, McNeish, I, Medley, LC, Michael, A, Nutting, CM, Pandha, HS, Shorrock, CA, Simpson, J, Steiner, J, Steven, NM, Wright, D and Coombes, RC (2006) A phase I study of OncoVEXGM-CSF, a second-generation oncolytic herpes simplex virus expressing granulocyte macrophage colony-stimulating factor Clin Cancer Res, 12 (22). pp. 6737-6747.

Simpson, GR, Han, Z, Liu, B, Wang, Y, Campbell, G and Coffin, RS (2006) Combination of a fusogenic glycoprotein, prodrug activation, and oncolytic herpes simplex virus for enhanced local tumor control CANCER RESEARCH, 66 (9). pp. 4835-4842.

Coffin, RS, Liu, B, Han, Z, Assenberg, M, Thomas, S, Hu, J and Simpson, G (2006) OncoVEX: A Family of Oncolytic Herpes Simplex Viruses Optimised for Therapeutic Use MOLECULAR THERAPY, 13. S64-S64.

Conference or Workshop Item

Horvath, A, Simpson, GR, Coffin, RS, Mostafid, AH and Pandha, H (2011) Update on a novel intravesical therapy for non muscle invasive bladder cancer: Combination of a fusogenic glycoprotein, pro-drug activation and oncolytic herpes simplex virus In: Annual Meeting of the Society-of-Academic-and-Research-Surgeons, 2010-01-06 - 2010-01-07, Royal Free Hosp, London, ENGLAND.

Pandha, S, Simpson, GR, Horvath, A, Coffin, RS, Pencavel, T and Harrington, K (2011) Combination of a fusogenic glycoprotein, pro-drug activation and oncolytic HSV as an intravesical therapy for superficial bladder cancer (visualised by micro CT) In: Annual Meeting of the Society-of-Academic-and-Research-Surgery, 2011-01-05 - 2011-01-06, Royal Coll Surgery, Dublin, IRELAND.

Horvath, A, Simpson, GR, Coffin, RS, Mostafid, H and Pandha, H (2010) NOVEL INTRAVESICAL THERAPY FOR NON MUSCLE INVASIVE BLADDER CANCER USING A GENETICALLY MODIFIED ONCOLYTIC HERPES SIMPLEX VIRUS

Simpson, GR, Horvath, A, Harrington, K, Coffin, RS and Pandha, H (2008) Combination of a fusogenic glycoprotein, pro-drug activation and oncolytic HSV as an intravesical therapy for superficial bladder cancer In: 20th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, 2008-10-21 - 2008-10-24, Geneva, SWITZERLAND.

This list was generated on Mon Nov 20 23:27:27 2017 UTC.

Information about this web site

© The University of Surrey, Guildford, Surrey, GU2 7XH, United Kingdom.
+44 (0)1483 300800